Literature DB >> 11092437

Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study.

G A Colditz1, B Rosner.   

Abstract

Because of the temporal relations between reproductive risk factors and incidence of breast cancer, the authors developed a nonlinear Poisson regression that accounts for time and summarizes risk to age 70 years. Reproductive risk factors, benign breast disease, use of postmenopausal hormones, weight, and alcohol intake were evaluated as risk factors. Among 58,520 women aged 30-55 years in 1980, followed through June 1, 1994, 1,761 incident invasive breast cancer cases were identified. All risks are multivariate adjusted. History of benign breast disease is associated with a 57% increase (95% confidence interval (CI): 43%, 73%) in cumulative risk of breast cancer by age 70 years. Use of unopposed postmenopausal estrogen from ages 50-60 years increases risk of breast cancer to age 70 by 23% (95% CI: 6%, 42%) compared with a woman who never uses hormones. Ten years of use of estrogen plus progestin increases risk to age 70 years by 67% (95% CI: 18%, 136%). Compared with never drinking alcohol, one drink per day from age 18 years increases risk to age 70 by 7% (95% CI: 0%, 13%). Use of unopposed postmenopausal hormones for 10 years significantly increases the risk of breast cancer, and the addition of progestin further increases the risk.

Entities:  

Mesh:

Year:  2000        PMID: 11092437     DOI: 10.1093/aje/152.10.950

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  133 in total

1.  Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk.

Authors:  Wendy Y Chen; Bernard Rosner; Susan E Hankinson; Graham A Colditz; Walter C Willett
Journal:  JAMA       Date:  2011-11-02       Impact factor: 56.272

2.  Interviews With Two Women's Health Experts On the Use of Estrogen Therapies.

Authors:  Maribeth Maher
Journal:  P T       Date:  2012-03

Review 3.  Time course of risk factors in cancer etiology and progression.

Authors:  Esther K Wei; Kathleen Y Wolin; Graham A Colditz
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

4.  Evaluation of a breast cancer risk prediction model expanded to include category of prior benign breast disease lesion.

Authors:  Rulla M Tamimi; Bernard Rosner; Graham A Colditz
Journal:  Cancer       Date:  2010-11-01       Impact factor: 6.860

Review 5.  Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations.

Authors:  Rodney Baber; Martha Hickey; Michelle Kwik
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

6.  A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer.

Authors:  David J Hunter; Peter Kraft; Kevin B Jacobs; David G Cox; Meredith Yeager; Susan E Hankinson; Sholom Wacholder; Zhaoming Wang; Robert Welch; Amy Hutchinson; Junwen Wang; Kai Yu; Nilanjan Chatterjee; Nick Orr; Walter C Willett; Graham A Colditz; Regina G Ziegler; Christine D Berg; Saundra S Buys; Catherine A McCarty; Heather Spencer Feigelson; Eugenia E Calle; Michael J Thun; Richard B Hayes; Margaret Tucker; Daniela S Gerhard; Joseph F Fraumeni; Robert N Hoover; Gilles Thomas; Stephen J Chanock
Journal:  Nat Genet       Date:  2007-05-27       Impact factor: 38.330

7.  Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk.

Authors:  Susan E Hankinson; A Heather Eliassen
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-24       Impact factor: 4.292

8.  Temporal trends in geographic disparities in small-area breast cancer incidence and mortality, 1988 to 2005.

Authors:  Mario Schootman; Min Lian; Anjali D Deshpande; Elizabeth A Baker; Sandi L Pruitt; Rebecca Aft; Donna B Jeffe
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-30       Impact factor: 4.254

9.  Application of the Rosner-Colditz risk prediction model to estimate sexual orientation group disparities in breast cancer risk in a U.S. cohort of premenopausal women.

Authors:  S Bryn Austin; Mathew J Pazaris; Bernard Rosner; Deborah Bowen; Janet Rich-Edwards; Donna Spiegelman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-03       Impact factor: 4.254

10.  Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis.

Authors:  Eleni Linos; Demetri Spanos; Bernard A Rosner; Katerina Linos; Therese Hesketh; Jian Ding Qu; Yu-Tang Gao; Wei Zheng; Graham A Colditz
Journal:  J Natl Cancer Inst       Date:  2008-09-23       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.